HSPGX
Price
$33.90
Change
+$0.53 (+1.59%)
Updated
Jun 2 closing price
Net Assets
1.49B
WCMLX
Price
$15.23
Change
+$0.18 (+1.20%)
Updated
Jun 2 closing price
Net Assets
53.09M
Interact to see
Advertisement

HSPGX vs WCMLX

Header iconHSPGX vs WCMLX Comparison
Open Charts HSPGX vs WCMLXBanner chart's image
HSPGX vs WCMLX Comparison Chart in %
View a ticker or compare two or three
VS
HSPGX vs. WCMLX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSPGX is a Buy and WCMLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HSPGX has more cash in the bank: 1.49B vs. WCMLX (53.1M). HSPGX (0.00) and WCMLX (0.00) have matching dividends . HSPGX was incepted earlier than WCMLX: HSPGX (34 years) vs WCMLX (7 years). WCMLX (1.79) is less costly to investors than HSPGX (1.04). WCMLX is a more actively managed with annual turnover of: 89.00 vs. HSPGX (45.00). HSPGX has a lower initial minimum investment than WCMLX: HSPGX (2000) vs WCMLX (100000). HSPGX annual gain was more profitable for investors over the last year : 47.85 vs. WCMLX (25.84). WCMLX return over 5 years is better than : -0.07 vs. HSPGX (-1.33).
HSPGXWCMLXHSPGX / WCMLX
Total Expense Ratio1.020.99103%
Annual Report Gross Expense Ratio1.041.7958%
Fund Existence34 years7 years-
Gain YTD24.0529.375257%
Front Load5%N/A-
Min. Initial Investment20001000002%
Min. Initial Investment IRAN/AN/A-
Net Assets1.49B53.1M2,800%
Annual Yield % from dividends0.000.00-
Returns for 1 year47.8525.84185%
Returns for 3 years55.4332.13172%
Returns for 5 years-1.33-0.072,001%
Returns for 10 years87.86N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERBX63.02N/A
N/A
American Funds EUPAC R2
GOGFX45.07N/A
N/A
Victory Sycamore Small Company Opp R
SGQAX48.41N/A
N/A
DWS International Opportunities A
PHLQX46.73N/A
N/A
PGIM Jennison Health Sciences R6
DLQIX15.32N/A
N/A
BNY Mellon Large Cap Equity I